Featured

LGFB Program Addresses Cancer-related Changes

Look Good Feel Better is designed to help women by giving them an effective intervention during their cancer treatment.

2017 ONA Navigation Summit Coverage

On-site coverage from the 2017 ONA Navigation Summit in Austin, Texas.

The Challenge of Rare Cancers

Roughly 13% of all cancers diagnosed in adults aged 20 years and older will be rare cancers.

Explore a combination therapy

Read about a triplet-based therapy for multiple myeloma patients who have received at least one prior treatment.

Got a Question?

Submit your oncology question today and let our experts respond!

For the treatment of metastatic non-small

Biomarker testing for epidermal growth factor receptor exon 19 deletions or exon 21 (L858R) substitution mutations is important when considering a first-line therapy

How Do You Use Social Media?

Take our brief survey and tell us!

Explore a combination therapy

Read about a triplet-based therapy for multiple myeloma patients who have received at least one prior treatment.

Features

Breast Cancer

3D Marker Improves Outcomes for BCS

Two recent studies examined the benefits of using a 3D bioabsorbable marker to indicate the tumor bed in women with breast cancer who underwent breast conserving surgery (BCS).

Breast Cancer

Late Effects of Taxane-based Chemotherapy

Breast cancer survivors who received taxane-based chemotherapy for their disease are at increased risk for falls due to CIPN and treatment-associated effects on balance and gait.

Advisor Forum

Putting a Name on the Impact of Cancer Treatment Costs

Putting a Name on the Impact of Cancer Treatment Costs

I hear the term "financial toxicity" used more and more when people are discussing the cost of cancer treatments. What exactly is financial toxicity?

Arsenic and APL: Review of Therapy for an Acute Leukemia

Arsenic and APL: Review of Therapy for an Acute Leukemia

I was surprised to see an order for arsenic recently. What is this being used for?

Preventing Tumor Lysis Syndrome in Patients Receiving Venetoclax

Preventing Tumor Lysis Syndrome in Patients Receiving Venetoclax

What precautions should be taken to prevent tumor lysis syndrome (TLS) in patients receiving venetoclax (Venclexta)?

Fact Sheets

Immune Thrombocytopenia (Fact Sheet)

Immune Thrombocytopenia (Fact Sheet)

This fact sheet examines immune thrombocytopenia (ITP), including patient outlook, treatment, and ITP in pregnancy.

Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)

Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)

This fact sheet examines the various kinds of chronic myeloproliferative neoplasms, and the tests utilized to detect and diagnose them.

Digital Issue

Editorial Board

Ann J. Brady, MSN, RN-BC

Jiajoyce R. Conway, DNP, FNP-BC, AOCNP

Marianne Davies, DNP, ACNP, AOCNP

Frank dela Rama, RN, MS, AOCNS

Donald R. Fleming, MD

Susanne Menon, MP, OCN

Leah A. Scaramuzzo, MSN, RN-BC, AOCN

Lisa A. Thompson, PharmD, BCOP

Rosemarie A. Tucci, RN, MSN, AOCN


     .

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs